Industries > Pharma > Needle-Free Delivery Technology Market 2018-2028

Needle-Free Delivery Technology Market 2018-2028

Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology

PUBLISHED: 21 August 2018
PAGES: 183
PRODUCT CODE: PHA0327
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0327 Categories: , Tags: , , , , , ,

The global needle-free delivery technology market was valued at $1.7bn in 2017 and is estimated to reach $5.5bn by 2028, growing at a CAGR of 11.5% from 2018-2028. In 2017, the Jet Injectors submarket held 45.1% of the global needle-free delivery technology market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 183-page report you will receive 107 charts– all unavailable elsewhere.

The 183-page report provides clear detailed insight into the global needle-free delivery technology market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Needle-Free Delivery Technology market forecasts from 2018-2028

Jet Injector submarket forecasts from 2018-2028

Competing Technology submarket forecast from 2018-2028, further segmented into:
• Novel Needle Technology
• Inhaler Technology
• Patch Technology

• This report also breaks down the revenue forecast for global needle-free delivery technology market by regional and national market:
• The US
• EU5: Germany, France, UK, Italy, Spain
• Japan
• China
• India

Needle-Free Delivery Technology Market 2018-2028

• This report discusses the leading companies that are involved in the needle-free delivery technology market. It contains overviews of the companies’ activities, strategies and recent financial results:
• 3M
• Antares Pharma
• Becton Dickinson
• BioJect Medical Technologies
• PharmaJet
• Zogenix

• This report provides a SWOT Analysis of the global needle-free delivery technology market.

Visiongain’s study is for everybody needing commercial analyses for the needle-free delivery technology market and leading companies. You will find data, trends and predictions. Please order our report now.

Buy our report today Needle-Free Delivery Technology Market Forecast 2018-2028: Jet Injector Technology, Competing Technologies, Novel Needle Technology, Inhaler Technology, Patch Technology.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Needle-Free Delivery Technology Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Needle-Free Delivery Technology Market 2018-2028


Latest Pharma news

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

READ

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

READ

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

READ

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

READ

Categories

Category